Why Hims & Hers Health Stock Is Crashing Today
Shares of Hims Hers Health (NYSE: HIMS) are imploding on Monday, down 32% as of 3:03 p.m. ET. The drop comes as the S 500 rose 0.8% and the Nasdaq Composite rose 0.7%.
Novo Nordisk announced it will cut ties with Hims Hers, saying the telehealth provider can no longer sell compounded versions of its blockbuster GLP-1 weight loss drug Wegovy.
Novo Nordisk announced this morning that it is ending a partnership with Hims Hers that allowed the telehealth provider to sell Novo's blockbuster weight-loss drug, Wegovy.
Source Fool.com
